Intrexon (XON) Tops Q1 EPS by 4c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/16/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- SanDisk upgraded at JPMorgan after investor day; shares climb
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Ziopharm Oncology Reports First Quarter 2018 Financial Results and Provides Corporate Update
May 10, 2018 4:01 PM EDT-Â Â Expanding Controlled IL-12 platform to explore additional tumor types
-Â Â Cash runway extended to 2Q 2019 with changes to Controlled IL-12 development plans
-Â Â ASCO poster to detail IL-12 data in breast cancer, glioblastoma, highlight potential for combination with checkpoint inhibitors
-Â Â Sleeping Beauty CAR-T cells manufactured in two days entering clinic in 2H
-Â Â Company to host conference call today at 4:30 p.m. ET
BOSTON, May 10, 2018 (GLOBE NEWSWIRE) --... More
